Urvashi Patel, Ph.D., is the vice president of data and analytics at the Evernorth Research Institute. In her role, she is ...

Undiagnosed, untreated, or undertreated symptoms of menopause can have negative impacts for employers because it can lead to ...

智通财经APP获悉，摩根士丹利发布研报，给予Hims & Hers(HIMS.US)“持股观望”评级，目标价40美元。大摩表示，远程医疗公司对品牌GLP-1药物的降价表明了一种策略，即在5月22日(FDA不对503b复合制剂商的司美格鲁肽(semaglutide)采取行动的最后期限)之后，通过投机主义的促销来吸引患者；而Hims & ...

分析师对信诺的表现做出了各种价格目标调整。Bernstein将目标价提高至373美元，同时维持市场表现评级，引用对信诺医疗保健业务增长潜力的担忧。Raymond James将目标价提高至385美元并重申强力买入评级，指出公司的核心保险业务表现优于预期。Jefferies也将目标价提高至397美元并维持买入评级，强调信诺特种业务的强劲表现。

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy (semaglutide) and Zepbound (tirzepatide) will not exceed $200. Wegovy has a ...

Working closely with internal teams, the students gain firsthand insight into real-world applications, fostering a startup ...

CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

Getting access to popular weight loss drugs will be simpler and cheaper for some.Health insurer Cigna (CI) announced a new deal for copay caps on Eli Lilly (LLY) and Novo Nordisk (NVO) weight loss ...

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...

Vermont Business Magazine This week, the Hinesburg community celebrated the official grand opening of Kelley’s Field II.

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.